It was a big biotech week with many signals including CGEN, SEGN, BMRN but this one failed to hold. No Model is perfect and anyone who isn't trading with a rules based model will always underperform in the long run. No strong emotions for winners so the same must be applied to losers. We will certainly get another shot at this. Ingenuity Trading Model is an...
My last chart: November 22, 2020: Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA (The Motley Fool). Regeneron Covid Drug Gets Emergency OK. Antibody drug cocktail casirivimab and imdevimab are allowed for use by people over age 12 with mild or moderate Covid-19. (the street). If you are interested...
The above references an opinion and is for information purposes only. It is not intended to be investment advice. Seek a duly licensed professional for investment advice.
Earlier this year there was the question : How do you invest in Coronavirus vaccine stocks? Now, we have the answer : YOU DONT. Chart looking bleak, and the support lines are weak. This could be due to a few reasons: - Lack of MAINSTREAM updates - NVAX actually has no other vaccines - Market volatility due to covid and elections - Investors are seeking less...
REGN likes to make these waves and this one all conveniently lines up with break down resistance and even bigger trend mid lines and what not. #NASDAQ35000HAT
REGN just got a big boost of exposure with Trump's treatment as a coming-out party. The stock just held range support and broke up through sloped resistance. A move above the 50-day is likely on tap for today.
All description on the chart. Please, don't forget to like and follow. Thank you.
Gilead Sciences , Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company's products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency...
What is XBi? XBI provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with...
Hard move up after reclaiming 200DMA(red). Being held up steadily by the 9DMA(green). Very overbought and gap has been filled from most recent dramatic drop in April. Look for consolidation around 9/13 soon before moves further up. No confirmation yet of slowdown though. On watch.
2 CASES POSSIBLE..as usual UP or DOWN.. Short term Long for REGN .. tgt 325-331 If dumps then we may touch 240 and 215 Currently long at 310. Stop 297.
Watch very congested area at 340, short it once that is broken.
Potential bounce to 365 area before falling again, target price at 183
The price is above 30MM, the slope of 30MM is positive! If the price breaks the resistant, It will be in phase 2. But if you take risks, maybe you should buy!